Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
acknowledged, advice, appeal, artwork, aspect, auxiliary, belonging, bowel, cautionary, cellular, chemistry, CMC, compliant, covenant, developmental, display, effectuated, endorsement, escalating, expressly, fullest, HHS, identification, immunopharmacology, Intelligence, IRA, mucosal, outpace, penalize, penalty, pharmacodynamic, plural, profound, quantified, randomly, refinance, refinancing, resident, sequential, shed, sponsorship, stable, text, therefrom, threat, TM, verified, visual, vitro
Removed:
AEs, amortized, antidilutive, asset, axial, biology, bona, built, canceled, categorized, ceased, closeout, confirmed, cytokine, detect, disparity, drove, exchanged, fide, forfeited, fulfilled, globally, greatest, harnessing, identical, ileum, Immunotherapy, lab, lesser, lymphocyte, measurement, method, modern, modulated, naturally, nominated, observable, occurring, parent, participant, partner, parvula, percent, persist, postponed, preceding, proportional, quoted, realization, recognizable, rehired, reliably, repurchased, requisite, resolution, rheumatoid, RSU, Science, SCORing, showed, Society, surrendered, sustained, temporarily, tissue, transform, tumor, unadjusted, unchanged, underwritten, unit, unobservable, Veillonella
Filing tables
Filing exhibits
EVLO similar filings
Filing view
External links
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Marella Thorell, as Chief Financial Officer, Senior Vice President and Treasurer of Evelo Biosciences, Inc. (the “Company”), hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
(1)the Company's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022 (the “Report”) fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 14, 2022 | By: | /s/ Marella Thorell | |||||||||||||||
Marella Thorell | |||||||||||||||||
Chief Financial Officer, Senior Vice President and Treasurer | |||||||||||||||||
(Principal Financial Officer) |